The precise synthesis of potent pharmaceuticals demands intermediates of the highest quality. At NINGBO INNO PHARMCHEM CO.,LTD., we specialize in providing such critical components, including the vital 2-(4-Chlorophenyl)-4,4-Dimethylcyclohex-1-Enecarbaldehyde, identified by its unique CAS No. 1228837-05-5. This compound is a cornerstone in the manufacturing process for Venetoclax, a significant therapeutic agent used in treating various hematological malignancies.

The chemical structure, C15H17ClO, represents a complex organic molecule where purity is paramount for the successful and safe synthesis of the final API. Our commitment to quality assurance ensures that each batch of CAS No. 1228837-05-5 meets rigorous international standards, including GMP, ISO 9001, and FDA compliance. This dedication to excellence guarantees that our clients receive a reliable and effective pharmaceutical intermediate, crucial for the consistent production of life-saving cancer drugs.

By supplying this indispensable chemical intermediate, NINGBO INNO PHARMCHEM CO.,LTD. plays a key role in supporting pharmaceutical companies dedicated to advancing cancer therapy. We understand that timely access to high-quality intermediates is essential for maintaining production schedules and meeting market demands. Our efficient logistics and robust supply chain management ensure that clients globally can depend on us for their critical raw material needs, facilitating breakthroughs in the treatment of diseases like leukemia. We focus on providing cost-effective solutions for essential API intermediates, making advanced treatments more accessible.

The strategic importance of intermediates like CAS No. 1228837-05-5 underscores the value NINGBO INNO PHARMCHEM CO.,LTD. brings to the pharmaceutical research and manufacturing sectors. We are dedicated to fostering innovation and contributing to the development of more effective treatments by providing the foundational chemical components that make modern medicine possible.